ATRX and neuroblastoma: The combination of these findings is in line with previous work demonstrating that neuroblastomas with a mesenchymal signature have a denser infiltration of inflammatory immune cells than adrenergic neuroblastomas [18] and thus we identify ATRX alterations as a probable driver of this previously described phenotype.